REGN Stock Analysis Overview
What this means: Regeneron Pharmaceuticals (REGN) gets an Overall Rank of 55, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. REGN's 55 means that it ranks higher than 55% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
REGN Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
REGN Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
REGN Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
REGN Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
REGN Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
REGN Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
REGN Stock Analysis Overview
What this means: Regeneron Pharmaceuticals (REGN) gets an Overall Rank of 55, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. REGN's 55 means that it ranks higher than 55% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.